Trials
14 active
15 in total · 14 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Endophthalmitis
- Main trialPhase 2/3
- “Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis”In the company’s words, NCT03244072 on ClinicalTrials.gov
- Other names
- Moxifloxacin
Coming up1
- Oct 2030Phase 2/3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials15
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2/3Not yet recruiting | Oct 2030 | Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery | |
| Phase 4Authorised | not given | Staphylococcus aureus Network Adaptive Platform trial (SNAP) | |
| Phase 4Authorised | not given | Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) | |
| Phase 4Authorised | not given | Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis: a Randomized Double-blind Placebo-controlled Noninferiority Trial APPAC IV | |
| Phase 2Authorised | not given | Finding the Optimal Regimen for Mycobacterium abscessus Treatment | |
| Phase 4Authorised | not given | Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study. | |
| Phase 3Authorised | not given | Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia | |
| Phase 3Authorised | not given | Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM). Phase 3 pragmatic multicenter open labelled randomized trial. | |
| Phase 2Ended | not given | RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB). | |
| Phase 3Authorised | not given | Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR) | |
| Phase 4Authorised | not given | Optimizing the antibiotic treatment of uncomplicated acute appendicitis: a prospective randomized multicenter study | |
| Phase 4Authorised | not given | Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study | |
| Phase 4Authorised | not given | Acute appendicitis and microbiota – etiology and effects of the antimicrobial treatment - MAPPAC | |
| Phase 4Authorised | not given | Rapid Oral Switch in Infectious Endocarditis, the ROSIE trial | |
| Phase 4Authorised | not given | Early switch to oral antibiotic therapy in vertebral osteomyelitis: a multicentre, open-label, randomised, active control, parallel group, non-inferiority trial (sWITCH-VO) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026